Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
AP
ACADIA PHARMACEUTICALS A/S
aktivCVR 19670694AktieselskabHesteskoen 3, 2880 BagsværdForskning og eksperimentel udvikling inden for naturvidenskab og teknik
- Latest accounts
- 2025
- Statement scope
- Standalone
- Verified
- 06 Nov 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2025
Revenue
Data quality concern—
Data quality concern
Operating profit
Data quality concern—
Data quality concern
Net result
DKK -471k
Latest period
Source details
Source: dk-regnskabsdata-live-19670694-1793927959019
Document: dk-regnskabsdata-19670694-AZ3jvGgkIfGsIONvbGYx-1
XBRL: d:ProfitLoss
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c1
Unit: u6
Equity
DKK -1.6m
Equity ratio: -11,085.6%
Source details
Source: dk-regnskabsdata-live-19670694-1793927959019
Document: dk-regnskabsdata-19670694-AZ3jvGgkIfGsIONvbGYx-1
XBRL: d:Equity
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c43
Unit: u6
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2022 | — | DKK -253.6k |
| 2023 | — | DKK -151.4k |
| 2024 | — | DKK -99.4k |
| 2025 | — | DKK -471k |